- NEWS
Alzheimer’s drug with modest benefits wins backing of FDA advisers
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-024-01726-w
References
Sims, J. R. et al. JAMA 330, 512–527 (2023).
Van Dyck, C. H. et al. N. Engl. J. Med. 388, 9–21 (2023).
Doran, S. J. & Sawyer, R. P. Front. Neurosci. 18, 1326784 (2024).